The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, is There Any Benefit?

MLA

Saffar, Hana, et al. “The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, Is There Any Benefit?” Asian Pacific Journal of Cancer Prevention : APJCP, vol. 22, no. 7, July 2021, pp. 2049–52. EBSCOhost, https://doi.org/10.31557/APJCP.2021.22.7.2049.

APA

Saffar, H., Okhovat, H., Arbabsoleymani, S., Tavangar, S. M., Khoshnevisan, A., Hajinasrollah, G., Hamidi Afra, Z., & Saffar, H. (2021). The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, is There Any Benefit? Asian Pacific Journal of Cancer Prevention : APJCP, 22(7), 2049–2052. https://doi.org/10.31557/APJCP.2021.22.7.2049

Chicago

Saffar, Hana, Hoda Okhovat, Saeed Arbabsoleymani, Seyed Mohammad Tavangar, Alireza Khoshnevisan, Ghazal Hajinasrollah, Zahra Hamidi Afra, and Hiva Saffar. 2021. “The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, Is There Any Benefit?” Asian Pacific Journal of Cancer Prevention : APJCP 22 (7): 2049–52. doi:10.31557/APJCP.2021.22.7.2049.